Just like allergy sufferers. And they are on the rise. For many people allergies can range from sniffling and sneezing to skin rashes to gastrointestinal issues. A certain percentage, however, have more than these uncomfortable symptoms to deal with. Anaphylaxis, a serious life-threatening reaction, causes approximately 1,500 deaths a year in the United States alone. Clearly, allergies are nothing to sneeze at!
Articles for Advocacy
Auvi-Q Offers Possible Alternative to Epi-Pen™
By Kristen Stewart
February 6th, 2017
Anyone with severe allergies knows the importance of having an epinephrine auto-injector (EAI) at the ready. However, with the Epi-PenTM jumping more than $500 in price in the last eight years and until recently no other companies having an epinephrine auto-injector device available, not everyone can afford this potentially life-saving medication. That may be about to change as Kaleo’s Auvi-Q re-enters the U.S. market ...
The Do’s and Don’ts of Preventing Peanut Allergies in Babies
After being told for years to avoid giving allergens such as peanuts and shellfish to children, the National Institute of Allergy and Infectious Diseases (NIAID) is now recommending that parents introduce children to peanuts in the first four to six months of life, based on their child’s risk level. Below are some excellent guidelines to help determine what that risk level might be and how to include peanuts in a baby’s diet. Always check with your pediatrician first before feeding your child any potential allergens.
Scientists say early and consistent feeding of peanuts can help prevent peanut allergies in children. A food allergy expert explains what parents should know.
By Rebecca Priest
January 31st, 2017
Food allergies have grown in prevalence and severity, and until recently pediatricians have told parents to keep their babies away from peanuts, shellfish and other common allergenic foods.
Lawmakers Say Mylan Stonewalling Them
Mylan remains on the hot seat as members of Congress become increasingly frustrated with the delay in obtaining requested documents. If Mylan does not provide the unedited information by Feb. 28, 2017, Congress has the right to subpoena them. The company has already agreed to pay the federal government $465 million to settle claims that it overcharged Medicaid for the EpiPen.
By Robert King
February 2nd, 2017
Two high-ranking members of Congress are clamoring for drug maker Mylan to produce documents about its controversial 400 percent price hike of the EpiPen.
Reps. Jason Chaffetz, R-Utah, and Elijah Cummings, D-Md., sent a letter Friday to Mylan, saying that the company hasn't produced enough documents "despite repeated requests." Chaffetz is chairman and Cummings the top Democrat of the House Oversight and Government Reform Committee, which held a hearing on Mylan last year.